CINCINNATI, Sept. 14 (UPI) -- Procter & Gamble Co. has over 1,200 trucks packed and ready to go Monday for the nationwide over-the-counter launch of its anti-heartburn drug, Prilosec.
The new drug could show up on some shelves the same day, The Cincinnati Post reported.
P&G predicts first-year sales of Prilosec OTC will fall somewhere between $200 million to $400 million, the Post said.
Already though, there is a major hurdle to be crossed.
The makers of Pepcid AC filed suit in federal court Friday, contesting the accuracy of Prilosec's advertising claims. Pepcid is the nation's No. 2 heartburn drug behind Tums.
P&G claims Prilosec OTC will provide relief for heartburn sufferers for 24 hours when used in a 14-day regimen.
A P&G spokesman told the Post the lawsuit would not cast a pallor on the roll-out.
"Our claims are absolutely true," he said.
